Updated: May 7, 2018
At the Prostate Cancer DREAM Challenge.
Over 50 teams, from around the world, competed in the Prostate Cancer DREAM Challenge, to predict the survival and toxicity of docetaxel treatment in patients with metastatic castrate resistant prostate cancer. Our team, PC LEARN, tied for 1st in one of the 2 specific subchallenges -- see here.
See the press release (we are "Canada" and "Israel"); and the article.
On behalf of this entire community, I am honoured and grateful to receive this award! https://www.amii.ca/latest-from-amii/russ-greiner-receives-caiac-lifetime-achievement-award/
IMIA Yearbook of Medical Informatics 2018, named our paper "A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer"
PhD student Felicity Allen has won the CASMI (Critical Assessment of Small Molecule Identification) competition for 2014. She won with her CFM-ID system, which finds the chemical structure of an ESI-M
